Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has elicited a global health crisis of catastrophic proportions. With only a few vaccines approved for early or limited use, there is a critical need for effective antiviral strategies. In this study, we report a unique antiviral pla...
| Main Authors: | , , , , , |
|---|---|
| Other Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Springer Science and Business Media LLC,
2020-11-30T19:51:09Z.
|
| Subjects: | |
| Online Access: | Get fulltext |